リック・ドブリン
Journal of Addictive Diseases 14 (1): 5–14. doi:10.1300/J069v14n01_02. PMID 7543287.
Doblin, R.; Kleiman, M. (1998). “Survey research vs clinical trials in evaluating the medical utility of marijuana”. Southern Medical Journal 91 (10): 989–91. doi:10.1097/00007611-199810000-00032. PMID 9786301. http://openurl.ebscohost.com/linksvc/linking.aspx?genre=article&sid=PubMed&issn=0038-4348&title=South%20Med%20J&volume=91&issue=10&spage=989&atitle=Survey%20research%20vs%20clinical%20trials%20in%20evaluating%20the%20medical%20utility%20of%20marijuana.&aulast=Doblin&date=1998.
Doblin, R. (1998). “Dr. Leary's Concord Prison Experiment”.
Journal of Psychoactive Drugs 30 (4): 419–426. doi:10.1080/02791072.1998.10399715. PMID 9924845. http://www.maps.org/research/1998_Doblin_ConcordPrisonFollow-up.pdf.
Regulation of the Medical Use of Psychedelics and Marijuana . A dissertation by R. Doblin for his Ph.D. in Public Policy from the Kennedy School of Government, Harvard University. June 2002.
Doblin, R. (Autumn 2002). “A Clinical Plan for MDMA (Ecstasy) in the Treatment of Post-traumatic Stress Disorder (PTSD): Partnering with the FDA”. MAPS Bulletin 12 (3): 5–18. http://www.maps.org/news-letters/v12n3/12305dob.pdf.
Mithoefer, M.; Jerome, L.; Doblin, R. (2003). “MDMA ('ecstasy') and neurotoxicity”. Science 300 (5625): 1504–5.